Previous Page  39 / 103 Next Page
Information
Show Menu
Previous Page 39 / 103 Next Page
Page Background

E

ffect

of

fluoride

on

salivary

immunoglobulins

and

sialic

acid

R

ev

A

ssoc

M

ed

B

ras

2017; 63(4):320-323

323

from babies including level of sialic acid, which was re-

duced as the children aged.

Salivary sialic acid levels were compared with those

of children with systemic problems. Two studies found

that salivary sialic acid levels were higher in healthy indi-

viduals than in children with Down syndrome.

8,23

How-

ever, this difference was significant in only one of the two

studies. Similarly, the salivary sialic acid level was found

to be higher in a control group than in diabetic children.

24

Patients with cystic fibrosis have been shown to have

significantly lower sialic acid concentrations compared

with a control group.

25

These differences in sialic acid

level have been interpreted as influenced more by the ef-

fects of systemic diseases than by local factors.

8

C

onclusion

In our study, gathering a large group of children using

the same parameters to standardize was quite difficult.

We conclude that sIgA and sIgG levels were higher in

children with dental fluorosis than in those with healthy

teeth, even though the difference was not significant.

Therefore, increased levels of sIgA and IgG in dental flu-

orosis may arrest the progression of dental caries. Given

the risks of dental fluorosis, further studies of the effects

of different fluoride levels in drinking water on salivary

characteristics are needed to confirm the results of our

study and to provide data for comparison. Studies con-

ducted in samples with features similar to those of our

study will increase the knowledge available.

R

eferences

1.

Nieuw Amerongen AV, Veerman ECI. Saliva-the defender of the oral cavity.

Oral Dis. 2002; 8(1):12-22.

2.

Sreebny LM. Saliva in health and disease: an appraisal and update. Int Dent

J. 2000; 50(3):140-61.

3.

Mandel ID. The role of saliva in maintaining oral homeostasis. J Am Dent

Assoc. 1989; 119(2):298-304.

4.

Dodds MWJ, Johnson DA, Yeh CK. Health benefits of saliva: a review. J Dent.

2005; 33(3):223-33.

5.

Llena-Puy C. The role of saliva in maintaining oral health and as an aid to

diagnosis. Med Oral Patol Oral Cir Bucal. 2006; 11(5):449-55.

6.

Närhi TO, Tenovuo J, Ainamo A, Vilja P. Antimicrobial factors, sialic acid,

and protein concentration in whole saliva of the elderly. Scand J Dent Res.

1994; 102(2):120-5.

7. Cogulu D, Sabah E, Kutukculer N, Ozkinay F. Evaluation of the relationship

between caries indices and salivary secretory IgA, salivary pH, buffering

capacity and flow rate in children with Down’s syndrome. Arch Oral Biol.

2006; 51(1):23-8.

8. Yarat A, Akyüz S, Koç L, Erdem H, Emekli N. Salivary sialic acid, protein,

salivary flow rate, pH, buffering capacity and caries indices in subjects with

Down’s syndrome. J Dent. 1999; 27(2):115-8.

9. Winer RA, Feller RP. Composition of parotid and submandibular saliva and

serum in Down’s syndrome. J Dent Res. 1972; 51(2):449-54.

10.

Jara L, Ondarza A, Blanco R, Rivera L. Composition of the parotid saliva in

Chilean children with Down’s syndrome. Arch Biol Med Exp (Santiago).

1991; 24(1):57-60.

11.

Riviere GR, Papagiannoulis L. Antibodies to indigenous and laboratory

strains of Streptococcus mutans in saliva from children with dental caries

and from caries-free children. Pediatr Dent. 1987; 9(3):216-20.

12.

Rose PT, Gregory RL, Gfell LE, Hughes CV. IgA antibodies to Streptococcus

mutans in caries-resistant and -susceptible children. Pediatr Dent. 1994;

16:272-6.

13.

Russell MW, Hajishengallis G, Childers NK, Michalek SM. Secretory

immunity in defense against cariogenic mutans streptococci. Caries Res.

1999; 33(1):4-15.

14. Katz J, Harmon CC, Buckner GP, Richardson GJ, Russell MW, Michalek SM.

Protective salivary immunoglobulin A responses against Streptococcus mutans

infection after intranasal immunization with S. mutans antigen I/II coupled

to the B subunit of cholera toxin. Infect Immun. 1993; 61(5):1964-71.

15.

Fontana M, Gfell LE, Gregory RL. Characterization of preparations enri-

ched for Streptococcus mutans fimbriae: salivary immunoglobulin A anti-

bodies in caries-free and caries-active subjects. Clin Diagn Lab Immunol.

1995; 2(6):719-25.

16.

Bratthall D, Serinirach R, Hamberg K, Widerström L. Immunoglobulin A

reaction to oral streptococci in saliva of subjects with different combina-

tion of caries and levels of mutans streptococci. Oral Microbiol Immunol.

1997; 12(4):212-8.

17. Thylstrup A, Fejerskov O. Clinical appearance of dental fluorosis in permanent

teeth in relation to histological changes. Commun Dent Oral Epidemiol.

1978; 6(6):315-28.

18. Axelsson P. Diagnosis and risk prediction of dental caries. Germany:

Quintessence Publishing Co; 2000.

19.

Martins-Gomez AM, Nicolau J, de Souza D, Oliveira EA. Study of some

parameters in stimulated saliva from adolescents with dental fluorosis. J

Oral Sci. 2001; 43(4):225-31.

20. Tram TH, Brand Miller JC, McNeil Y, McVeagh P. Sialic acid content of

infant saliva: comparison of breast fed with formula fed infants. Arch Dis

Child. 1997; 77(4):315-8.

21. Wang B, Miller JB, Sun Y, Ahmad Z, McVeagh P, Petocz P. A longitudinal

study of salivary sialic acid in preterm infants: comparison of human milk-

fed versus formula-fed infants. J Pediatr. 2001; 138(6):914-6.

22. Dezan CC, Nicolau J, Souza DN, Walter LRF. Flow rate, amylase activity, and

protein and sialic acid concentrations of saliva from children aged 18, 30 and

42 months attending a baby clinic. Arch Oral Biol. 2002; 47(6):423-7.

23.

Siqueria WL, Nicolau J. Stimulated whole saliva components in children

with Down syndrome. Special Care Dentist. 2002; 22(6):226-30.

24. Akyüz S, Yarat A, Erdem H, Koç L, Emekli N,

İ

ş

büsker A. Tip I ve Tip II di-

yabetik hastalarda di

ş

çürü

ğ

ü, periodontal durum ile bazı tükürük para-

metreleri ve tükürük, serum, mikrobiyal dental plak sialik asit düzeyleri

arasındaki ili

ş

kinin incelenmesi. Türk Diyabet Yıllı

ğ

ı. 1997-1998:1-15.

25.

da Silva Modesto KB, de Godói Simões JB, de Souza AF, Damaceno N, Duarte

DA, Leite MF, et al. Salivary flow rate and biochemical composition analysis

in stimulated whole saliva of children with cystic fibrosis. Arch Oral Biol.

2015; 60(11):1650-4.

26.

Pannunzio E, Amancio OM, Vitalle MS, Souza DN, Mendes FM, Nicolau J.

Analysis of the stimulated whole saliva in overweight and obese school

children. Rev Assoc Med Bras. 2010; 56(1):32-6.